Navamedic ASA (NAVA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Navamedic ASA (NAVA) has a cash flow conversion efficiency ratio of 0.077x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr25.59 Million ≈ $2.69 Million USD) by net assets (Nkr334.08 Million ≈ $35.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NAVA equity to assets ratio to measure how much of total assets are equity-financed.
Navamedic ASA - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Navamedic ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Navamedic ASA cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Navamedic ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Navamedic ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Groupe Partouche SA
PA:PAR
|
-0.012x |
|
Better Life Group Co Ltd
TW:1805
|
-0.011x |
|
Phunware Inc
NASDAQ:PHUN
|
-0.029x |
|
Man Group PLC
LSE:EMG
|
-0.090x |
|
Arianne Phosphate Inc
V:DAN
|
-0.019x |
|
Dong-A Hwa Sung Co.Ltd
KQ:041930
|
-0.003x |
|
Modernform Group Public Company Limited
BK:MODERN
|
0.018x |
|
Marathon Bancorp, Inc. Common Stock
NASDAQ:MBBC
|
2.645x |
Annual Cash Flow Conversion Efficiency for Navamedic ASA (2003–2025)
The table below shows the annual cash flow conversion efficiency of Navamedic ASA from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Navamedic ASA (NAVA) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr334.08 Million ≈ $35.15 Million |
Nkr25.59 Million ≈ $2.69 Million |
0.077x | -53.21% |
| 2024-12-31 | Nkr240.44 Million ≈ $25.30 Million |
Nkr39.35 Million ≈ $4.14 Million |
0.164x | +1570.51% |
| 2023-12-31 | Nkr222.39 Million ≈ $23.40 Million |
Nkr2.18 Million ≈ $229.29K |
0.010x | -88.55% |
| 2022-12-31 | Nkr209.72 Million ≈ $22.07 Million |
Nkr17.94 Million ≈ $1.89 Million |
0.086x | +1095.23% |
| 2021-12-31 | Nkr151.24 Million ≈ $15.91 Million |
Nkr-1.30 Million ≈ $-136.80K |
-0.009x | +65.00% |
| 2020-12-31 | Nkr129.49 Million ≈ $13.63 Million |
Nkr-3.18 Million ≈ $-334.63K |
-0.025x | -115.29% |
| 2019-12-31 | Nkr79.23 Million ≈ $8.34 Million |
Nkr12.72 Million ≈ $1.34 Million |
0.161x | +144.27% |
| 2018-12-31 | Nkr99.32 Million ≈ $10.45 Million |
Nkr-36.02 Million ≈ $-3.79 Million |
-0.363x | -159.37% |
| 2017-12-31 | Nkr96.70 Million ≈ $10.18 Million |
Nkr59.07 Million ≈ $6.22 Million |
0.611x | +545.20% |
| 2016-12-31 | Nkr105.73 Million ≈ $11.13 Million |
Nkr-14.51 Million ≈ $-1.53 Million |
-0.137x | -171.72% |
| 2015-12-31 | Nkr118.28 Million ≈ $12.45 Million |
Nkr22.63 Million ≈ $2.38 Million |
0.191x | +297.98% |
| 2014-12-31 | Nkr111.23 Million ≈ $11.70 Million |
Nkr-10.75 Million ≈ $-1.13 Million |
-0.097x | +33.78% |
| 2013-12-31 | Nkr107.26 Million ≈ $11.29 Million |
Nkr-15.65 Million ≈ $-1.65 Million |
-0.146x | -117.92% |
| 2012-12-31 | Nkr96.68 Million ≈ $10.17 Million |
Nkr-6.47 Million ≈ $-681.19K |
-0.067x | -6435.86% |
| 2011-12-31 | Nkr93.24 Million ≈ $9.81 Million |
Nkr-95.52K ≈ $-10.05K |
-0.001x | +99.24% |
| 2010-12-31 | Nkr100.21 Million ≈ $10.54 Million |
Nkr-13.46 Million ≈ $-1.42 Million |
-0.134x | -811.95% |
| 2009-12-31 | Nkr111.78 Million ≈ $11.76 Million |
Nkr-1.65 Million ≈ $-173.31K |
-0.015x | +84.76% |
| 2008-12-31 | Nkr110.24 Million ≈ $11.60 Million |
Nkr-10.66 Million ≈ $-1.12 Million |
-0.097x | -324.44% |
| 2007-12-31 | Nkr128.99 Million ≈ $13.57 Million |
Nkr5.56 Million ≈ $584.83K |
0.043x | +124.42% |
| 2006-12-31 | Nkr60.87 Million ≈ $6.40 Million |
Nkr-10.74 Million ≈ $-1.13 Million |
-0.176x | -144.73% |
| 2005-12-31 | Nkr43.19 Million ≈ $4.54 Million |
Nkr-3.11 Million ≈ $-327.70K |
-0.072x | +62.10% |
| 2004-12-31 | Nkr19.03 Million ≈ $2.00 Million |
Nkr-3.62 Million ≈ $-381.04K |
-0.190x | +68.79% |
| 2003-12-31 | Nkr7.21 Million ≈ $758.70K |
Nkr-4.40 Million ≈ $-462.53K |
-0.610x | -- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more